Femo Labs Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 13-12-2024
- Paid Up Capital ₹ 2.00 M
as on 13-12-2024
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 58.77%
(FY 2020)
- Profit 90.72%
(FY 2020)
- Ebitda 144.23%
(FY 2020)
- Net Worth -2.42%
(FY 2020)
- Total Assets 22.71%
(FY 2020)
About Femo Labs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Syed Kassali, Rameesabegam, Riswana, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900TN2013PTC093502
- Company No.
093502
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Femo Labs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Syed Kassali  | Director | 30-Nov-2021 | Current |
| Rameesabegam | Director | 25-Mar-2019 | Current |
| Riswana | Director | 25-Mar-2019 | Current |
| Mohamed Meeran | Director | 30-Oct-2013 | Current |
Financial Performance of Femo Labs.
Femo Labs Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 58.77% increase. The company also saw a substantial improvement in profitability, with a 90.72% increase in profit. The company's net worth dipped by a decrease of 2.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Femo Labs?
In 2018, Femo Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Unique Creations Software India Private LimitedActive 7 years 10 monthsMohamed Meeran is a mutual person
Amba Childcare Products Private LimitedActive 10 years 3 monthsSyed Kassali, Rameesabegam and 2 more are mutual person
- Amba Fluorochem Global LimitedActive 14 years 10 months
Syed Kassali, Rameesabegam and 1 more are mutual person
- Olympia Eco Solutions Private LimitedActive 11 years 4 months
Syed Kassali, Rameesabegam and 2 more are mutual person
- Gnanam Srinivas Chemicals & Equipments Private LimitedActive 24 years 9 months
Rameesabegam and Mohamed Meeran are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Femo Labs?
Unlock and access historical data on people associated with Femo Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Femo Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Femo Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
